Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 1 2Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 7Lymphoid 4Sarcoma 3Head & Neck 3Thoracic 2Other solid neoplasm 2Other hematologic neoplasm 2Myeloid 2Gynecologic 2Breast 2Tumor-Agnostic 1Genitourinary 1

Conditions

Ovarian Neoplasms 2Fallopian Tube Neoplasms 1

Interventions

Paclitaxel 108Carboplatin 97pembrolizumab 64Cisplatin 63Cyclophosphamide 45Bevacizumab 35Taxes 31Gemcitabine 28liposomal doxorubicin 27Topotecan 26fludarabine 25olaparib 22Nivolumab 20Docetaxel 20Radiotherapy 18Brachytherapy 17veliparib 16Magnetic Resonance Spectroscopy 16Doxorubicin 16Biopsy 15Radiation 14niraparib 13aldesleukin 13Specimen Handling 13Platinum 13Oxaliplatin 13Filgrastim 13Albumin-Bound Paclitaxel 12atezolizumab 11Interleukin-2 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Valproic Acid × Gynecologic × Clear all
NCT02520115 2019-08-14

Folate Receptor in Diagnosing Ovarian Cancer Using Serum Samples From Patients With Newly Diagnosed Pelvic Mass or Previously Diagnosed Ovarian Cancer

Barbara Ann Karmanos Cancer Institute

Phase 1 Completed
50 enrolled
Gynecologic

Ovarian Neoplasms

NCT00529022 2013-02-20

Azacitidine and Valproic Acid Plus Carboplatin in Patients With Ovarian Cancer

M.D. Anderson Cancer Center

Phase 1 Completed
36 enrolled
Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡